Terms ending in 2029
Every in-force patent on Pharmacyclics, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,906,954 | Selective Inhibitors of Histone Deacetylase In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| US 7,820,711 | Uses of Selective Inhibitors of HDAC8 for Treatment of T-Cell Proliferative Disorders In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| US 9,107,924 | Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| US 9,795,605 | Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| US 8,883,435 | Inhibitors of Bruton's Tyrosine Kinase Grace period ended Nov 11, 2026 · lapse expected · Low confidence | Pharmacyclics LLC | Grace period ended Nov 11, 2026 lapse expected | Low confidence | |
| US 7,718,662 | Pyrazolo-Pyrimidine Inhibitors of Bruton's Tyrosine Kinase In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 7,741,330 | Pyrazolo-Pyrimidine Inhibitors of Bruton's Tyrosine Kinase In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 9,012,463 | Inhibitors of Bruton's Tyrosine Kinase In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 9,278,100 | Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.